Neil Buckley is the founder of Lusaris Therapeutics. Lusaris Therapeutics has raised $60M in total funding. Latest round: Series A. Based in Boston, USA.
Neil Buckley, M.S. (Master of Science) served as the Chief Operating Officer of Lusaris Therapeutics, a biotechnology company focused on developing neuroplastogen therapeutics for severe neuropsychiatric and neurological disorders. He brought deep biotechnology expertise to the company. Lusaris Therapeutics launched in November 2022 with a $60 million Series A financing.
Full founder directory · Investor directory · Company funding database · Fundraising library